Filters

PAP2B Antibody

PAP2B Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long namePAP2B Primary Polyclonal Antibody
Also known asPAP2B PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenPAP2B
SpecificityThis is a highly specific antibody against PAP2B
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
Immunogen range258-285/311
Subcellular locationHelical
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human PAP2B
Gene ID number8613
Swiss ProtO14495
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen C-1-P >, In addition it hydrolyzes lysophosphatidic acid (LPA), May be involved in cell adhesion and in cell-cell interactions, S-1-P, The relative catalytic efficiency is LPA = PA >, ceramide-1-phosphate (C-1-P) and sphingosine-1-phosphate (S-1-P), Catalyzes the conversion of phosphatidic acid (PA) to diacylglycerol (DG)
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names Dri42, Lipid phosphate phosphohydrolase 3, PAP-2b, PAP2-beta, PAP2B, PPAP2B, Phosphatidate phosphohydrolase type 2b, Phosphatidic acid phosphatase 2b, VCIP, Vascular endothelial growth factor and type I collagen-inducible protein, LPP3
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetPAP2B
Short namePAP2B Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative namePAP2B (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter